Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Assets Average (2021 - 2025)

Coeptis Therapeutics Holdings has reported Assets Average over the past 5 years, most recently at $15.2 million for Q4 2025.

  • Quarterly results put Assets Average at $15.2 million for Q4 2025, up 69.81% from a year ago — trailing twelve months through Dec 2025 was $15.2 million (up 69.81% YoY), and the annual figure for FY2025 was $12.5 million, up 85.93%.
  • Assets Average for Q4 2025 was $15.2 million at Coeptis Therapeutics Holdings, up from $13.2 million in the prior quarter.
  • Over the last five years, Assets Average for COEPW hit a ceiling of $76.5 million in Q2 2021 and a floor of $4.0 million in Q2 2024.
  • Median Assets Average over the past 5 years was $12.8 million (2025), compared with a mean of $23.4 million.
  • Biggest five-year swings in Assets Average: crashed 87.99% in 2023 and later soared 216.88% in 2025.
  • Coeptis Therapeutics Holdings' Assets Average stood at $41.6 million in 2021, then tumbled by 50.42% to $20.6 million in 2022, then plummeted by 77.58% to $4.6 million in 2023, then soared by 93.3% to $8.9 million in 2024, then soared by 69.81% to $15.2 million in 2025.
  • The last three reported values for Assets Average were $15.2 million (Q4 2025), $13.2 million (Q3 2025), and $12.8 million (Q2 2025) per Business Quant data.